Screener
Olema Pharmaceuticals, Inc. OLMA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from exercise of stock options | 8,430 | 236 |
| Tax withholding for stock options exercised | (4,407) | — |
| Net cash provided by financing activities | 45,704 | 222 |
| Net increase (decrease) in cash and cash equivalents | 4,246 | (88,840) |
| Cash and cash equivalents at beginning of period | 48,301 | 139,480 |
| Cash and cash equivalents at end of period | $52,547 | $50,640 |
| Supplemental disclosure of non-cash financing activity | ||
| Exchange of common stock for pre-funded warrants | - | $29,379 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s net change in cash?
- Olema Pharmaceuticals, Inc. (OLMA) reported net change in cash of $4.25M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Olema Pharmaceuticals, Inc.'s net change in cash increased by 104.8% year-over-year, from -$88.84M to $4.25M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Olema Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude